SpyGlass Pharma Inc. Company Profile
NASDAQ: SGPHealth CareMedical/Dental InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 24.62 0.00%
SpyGlass Pharma at a glance
SpyGlass Pharma Inc. (NASDAQ: SGP) is a Medical/Dental Instruments company in the Health Care sector headquartered in Irvine, CA. SpyGlass Pharma is led by Mr. Patrick H. Mooney and employs about 76 people. The company's shares have traded publicly since 2026.
At a market capitalization of $823.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001778922, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does SpyGlass Pharma do?
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.
Business description based on the company's public filings.
Company information
- Legal name
- SpyGlass Pharma Inc.
- Ticker
- NASDAQ: SGP
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Patrick H. Mooney
- Employees
- 76
- Headquarters
- 15326 Alton Parkway, Irvine, CA, United States
- Phone
- 949 284 6904
- Website
- spyglasspharma.com
- IPO year
- 2026
- Market cap
- $823.49M
- SEC CIK
- 0001778922
Companies similar to SpyGlass Pharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SIBNSI-BONE Inc. | 18.86 | -1.26% | $845.28M | vs SGP |
| BVSBioventus Inc. Class A | 12.69 | -0.63% | $866.79M | vs SGP |
| BBNXBeta Bionics Inc. | 17.43 | -3.60% | $940.28M | vs SGP |
| MDXGMiMedx Group Inc | 4.62 | +0.22% | $674.22M | vs SGP |
| PRCTPROCEPT BioRobotics Corporation | 17.90 | -0.06% | $1.02B | vs SGP |
| AORTArtivion Inc. | 21.21 | -1.85% | $1.03B | vs SGP |
| IARTIntegra LifeSciences Holdings Corporation | 13.41 | +3.15% | $1.04B | vs SGP |
| KIDSOrthoPediatrics Corp. | 21.76 | -3.20% | $568.15M | vs SGP |